1.	Phase III Randomized Study of Different Combinations of Granisetron Hydrochloride, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron Hydrochloride in Preventing Delayed Nausea in Patients Undergoing Chemotherapy for Chemotherapy-Naive Breast Cancer Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: URCC-04-02, URCC 0402, URCC-U1105, U1105, NCT00475085
2.	Phase III Randomized Study of Palonosetron Hydrochloride and Dexamethasone With or Without Dronabinol in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy for Solid tumors Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MDA-2006-0841, 2006-0841, NCT00553059
3.	Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0961, NCT00542542
4.	Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 15 and over Sponsor: Other Protocol IDs: QL05-37, NCT00572572
5.	Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0801009584, NCT00645138
6.	Phase III Randomized Study of Gabapentin in Preventing Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N08C3, N08C3, NCT00880191
7.	Phase 3 Study of Tavocept vs Placebo in Patients With Newly Diagnosed or Relapsed Advanced (Stage IIIB/IV) Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DMS32212R, NCT00966914
8.	A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 7136-05-6R0/00007559, NCT00314808
9.	Phase II Randomized Study of Acupuncture in Reducing Postoperative Ileus in Patients Who Have Undergone Segmental or Subtotal Colectomy for Colorectal Cancer Phase: Phase II Type: Supportive care Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: MSKCC-06145, NCT00425412
10.	Dexamethasone for Symptom Burden in Advanced Cancer Patients Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2005-0816, NCT00489307
11.	Phase II Pilot Study of Palonosetron Hydrochloride, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma or Lymphoma Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: KUMC-10862, 10862, MGI-KUMC-10862, NCT00631930
12.	Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 00002273, NCT00636805
13.	Phase II Study of Ondansetron Hydrochloride for the Prevention of Dimethyl Sulfoxide-Related Nausea and Vomiting in Patients Receiving Cryopreserved Autologous Peripheral Blood Stem Cells Phase: Phase II Type: Supportive care Status: Active Age: 21 and over Sponsor: NCI Protocol IDs: FHCRC-2247.00, FHCRC-2247.00, IR-6765, NCT00795769
14.	Phase II Study of Fosaprepitant Dimeglumine in Combination With Palonosetron Hydrochloride and Dexamethasone for the Prevention of Cisplatin-Induced Nausea and Vomiting in Patients With Stage III or IV Squamous Cell Carcinoma of the Head and Neck Undergoing Concurrent Chemotherapy and Radiotherapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 70 Sponsor: NCI Protocol IDs: UWCC-6862, UWCC-6862, IR-6862, NCT00895245
15.	Phase II Randomized Pilot Study of Palonosetron Hydrochloride in Preventing Radiotherapy-Induced Nausea and Vomiting in Patients With Primary Gastrointestinal and/or Retroperitoneal Sarcomas Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N08C2, N08C2, NCT00903396
16.	Ondansetron Versus Aprepitant Plus Ondansetron for Emesis Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0615, NCT00954941
17.	Cyclophosphamide Drug Interaction Study In Cancer Patients Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NKV103444, NCT00334646
18.	Randomized Study of Electroacupuncture for Treatment of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Newly Diagnosed Pediatric Sarcoma, Neuroblastoma, Nasopharyngeal Carcinoma, Germ Cell Tumors, or Hodgkin Lymphoma Phase: No phase specified Type: Supportive care Status: Active Age: 5 to 35 Sponsor: NCCAM, NCI Protocol IDs: NCCAM-02-AT-0172, NCI-02-AT-0172, COG-ACCL04C2, ACCL04C2, NCT00040911
19.	Pilot, Randomized Study of Mindfulness Relaxation Versus Relaxing Music Versus Standard Symptom Management Education in Patients With Newly Diagnosed Solid Tumors Undergoing Chemotherapy Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MDA-CCC-0106, MDA-2004-0024, NCT00086762
20.	Study of Dexamethasone in Combination With Either Ondansetron or Palonosetron Hydrochloride in Preventing Acute and Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Early-Stage Breast Cancer Undergoing Chemotherapy Comprising Doxorubicin Hydrochloride and Cyclophosphamide Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UWCC-6140, UWCC-UW-6140, UWCC-05-9579-H/D, FHCRC-6140, MGI-FHCRC-6140, NCT00343863
21.	Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 2005-0664, NCT00410488
22.	Effects of Mirtazapine on Appetite in Advanced Cancer Patients Phase: No phase specified Type: Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 2005-0916, NCT00488072
23.	Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: Seigen Safety Trial: Cancer, WIRB Study No. 1085894, WIRB Pr. No. 20062258, NCT00606970
24.	Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-1033, NCT00651755
25.	Randomized Study of the Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UNC-LCCC-0514, UNC-05-2917, UNC-GCRC-2411-ORC, NCT00719173